Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alopecia Totalis/Universalis”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Not applicableStudy completedNCT05098600
What this trial is testing

The Epidemiology, Management and Comorbidities in Alopecia Areata in Czech Republic

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis+24 more
Faculty Hospital Kralovske Vinohrady 123
Testing effectiveness (Phase 2)Study completedNCT02812342
What this trial is testing

Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Yale University 10
Post-approval studies (Phase 4)Study completedNCT01167946
What this trial is testing

Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata

Who this might be right for
Alopecia TotalisAlopecia UniversalisOphiasic Alopecia
King Saud University 42
Large-scale testing (Phase 3)Active Not RecruitingNCT06873945
What this trial is testing

2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 550
Not applicableLooking for participantsNCT06283316
What this trial is testing

Systemic Treatments for Alopecia Areata Registry

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis+5 more
Erasmus Medical Center 10,000
Testing effectiveness (Phase 2)Ended earlyNCT04517864
What this trial is testing

PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA

Who this might be right for
Alopecia Areata
Pfizer 71
Testing effectiveness (Phase 2)Study completedNCT02197455
What this trial is testing

Tofacitnib for the Treatment of Alopecia Areata and Variants

Who this might be right for
Alopecia Areata (AA)Alopecia Totalis (AT)Alopecia Universalis (AU)
Yale University 30
Not applicableAvailableNCT05522556
What this trial is testing

Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)

Who this might be right for
Alopecia Areata
Pfizer
Post-approval studies (Phase 4)Study completedNCT03800979
What this trial is testing

Effectiveness and Safety of Tofacitinib in Patients With Extensive and Recalcitrant Alopecia Areata

Who this might be right for
Alopecia Areata
Institute of Dermatology, Thailand 19
Testing effectiveness (Phase 2)Study completedNCT03315689
What this trial is testing

Safety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)

Who this might be right for
Alopecia Universalis (AU)Alopecia Totalis (AT)
Aclaris Therapeutics, Inc. 11
Large-scale testing (Phase 3)Study completedNCT04006457
What this trial is testing

Long-Term PF-06651600 for the Treatment of Alopecia Areata

Who this might be right for
Alopecia Areata
Pfizer 1,057
Testing effectiveness (Phase 2)Ended earlyNCT02553330
What this trial is testing

A Study With Ruxolitinib Phosphate Cream Applied Topically to Subjects With Alopecia Areata (AA)

Who this might be right for
Alopecia Areata
Incyte Corporation 90
Testing effectiveness (Phase 2)WithdrawnNCT04238091
What this trial is testing

Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Lindsey Bordone
Testing effectiveness (Phase 2)Study completedNCT02684097
What this trial is testing

A Pilot Study of Tralokinumab in Subjects With Moderate to Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Emma Guttman 22
Testing effectiveness (Phase 2)Study completedNCT03594227
What this trial is testing

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis

Who this might be right for
Alopecia
Aclaris Therapeutics, Inc. 87
Not applicableActive Not RecruitingNCT00069589
What this trial is testing

Alopecia Areata Registry

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis+2 more
M.D. Anderson Cancer Center 3,100
Large-scale testing (Phase 3)Study completedNCT00997815
What this trial is testing

The Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia Universalis

Who this might be right for
Recalcitrant Alopecia TotalisRecalcitrant Alopecia Universalis
Siriraj Hospital 20
Testing effectiveness (Phase 2)UnknownNCT04011748
What this trial is testing

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata

Who this might be right for
Alopecia AreataAlopecia TotalisAlopecia Universalis
Throne Biotechnologies Inc. 20
Testing effectiveness (Phase 2)Study completedNCT02299297
What this trial is testing

Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis

Who this might be right for
Alopecia Areata
Columbia University 12
Not applicableStudy completedNCT07101471
What this trial is testing

Rhofanib® (Tofacitinib) Safety and Effectiveness Evaluation

Who this might be right for
Alopecia Totalis/UniversalisAlopecia Areata(AA)
NanoAlvand 296
Load More Results